Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NASDAQ:CERT

Certara - CERT Stock Forecast, Price & News

$15.88
-0.61 (-3.70%)
(As of 11/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$15.69
$16.52
50-Day Range
$10.65
$16.49
52-Week Range
$10.60
$29.99
Volume
418,805 shs
Average Volume
930,594 shs
Market Capitalization
$2.54 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.14

Certara MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
45.7% Upside
$23.14 Price Target
Short Interest
Healthy
2.18% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.73
Upright™ Environmental Score
News Sentiment
0.53mentions of Certara in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$974,267 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

380th out of 1,044 stocks

Prepackaged Software Industry

104th out of 221 stocks

CERT stock logo

About Certara (NASDAQ:CERT) Stock

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Receive CERT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Certara and its competitors with MarketBeat's FREE daily newsletter.

CERT Stock News Headlines

Why Certara's Shares Rose 37.7% This Week
Certara Reports Third Quarter 2022 Financial Results
Certara, Inc. (CERT) Q3 Earnings Miss Estimates
Certara: A Story To Watch (NASDAQ:CERT) - Seeking Alpha
Oversold Conditions For Certara (CERT) - Nasdaq
Analyst Ratings for Certara
Expert Ratings for Certara
See More Headlines
Receive CERT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Certara and its competitors with MarketBeat's FREE daily newsletter.

CERT Company Calendar

Last Earnings
11/08/2021
Today
11/27/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/07/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CERT
Fax
N/A
Employees
1,114
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$23.14
High Stock Price Forecast
$31.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+45.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$-13,270,000.00
Pretax Margin
4.59%

Debt

Sales & Book Value

Annual Sales
$286.10 million
Cash Flow
$0.27 per share
Book Value
$6.60 per share

Miscellaneous

Free Float
153,254,000
Market Cap
$2.54 billion
Optionable
Not Optionable
Beta
1.09

Key Executives

  • Dr. William F. Feehery Ph.D.Dr. William F. Feehery Ph.D. (Age 51)
    CEO & Director
    Comp: $1.24M
  • Mr. M. Andrew Schemick (Age 48)
    Chief Financial Officer
    Comp: $568.7k
  • Mr. Leif E. Pedersen (Age 58)
    Pres of Software
    Comp: $434.11k
  • Dr. Robert P. Aspbury Ph.D. (Age 50)
    Pres of Simcyp Division
    Comp: $541.23k
  • Mr. Andrew Schemick
    Chief Financial Officer
  • Prof. Amin Rostami PharmD
    Ph.D., FCP, Chief Scientific Officer
  • Mr. Richard M. TraynorMr. Richard M. Traynor (Age 50)
    Sr. VP, Gen. Counsel & Sec.
  • Mr. Ron DiSantis
    Sr. VP of Corp. Devel.
  • Ms. Nicolette D. Sherman (Age 52)
    Chief HR Officer
  • Mr. Jaap Mandema
    Chief Innovation Officer













CERT Stock - Frequently Asked Questions

Should I buy or sell Certara stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Certara in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CERT shares.
View CERT analyst ratings
or view top-rated stocks.

What is Certara's stock price forecast for 2023?

7 brokers have issued 1 year price objectives for Certara's stock. Their CERT share price forecasts range from $17.00 to $31.00. On average, they expect the company's share price to reach $23.14 in the next year. This suggests a possible upside of 45.7% from the stock's current price.
View analysts price targets for CERT
or view top-rated stocks among Wall Street analysts.

How have CERT shares performed in 2022?

Certara's stock was trading at $28.42 at the beginning of the year. Since then, CERT shares have decreased by 44.1% and is now trading at $15.88.
View the best growth stocks for 2022 here
.

When is Certara's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023.
View our CERT earnings forecast
.

How were Certara's earnings last quarter?

Certara, Inc. (NASDAQ:CERT) released its quarterly earnings data on Monday, November, 8th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.06 by $0.01. The company had revenue of $73.94 million for the quarter, compared to analysts' expectations of $73.90 million. Certara had a negative net margin of 1.28% and a positive trailing twelve-month return on equity of 4.25%.

What guidance has Certara issued on next quarter's earnings?

Certara updated its FY 2022 earnings guidance on Monday, November, 21st. The company provided earnings per share (EPS) guidance of $0.43-$0.48 for the period, compared to the consensus estimate of $0.45. The company issued revenue guidance of $325.00 million-$335.00 million, compared to the consensus revenue estimate of $330.74 million.

When did Certara IPO?

(CERT) raised $500 million in an initial public offering (IPO) on Friday, December 11th 2020. The company issued 24,400,000 shares at a price of $19.00-$22.00 per share. Jefferies, Morgan Stanley, BofA Securities, Credit Suisse, Barclays and William Blair acted as the underwriters for the IPO.

What is Certara's stock symbol?

Certara trades on the NASDAQ under the ticker symbol "CERT."

Who are Certara's major shareholders?

Certara's stock is owned by a number of retail and institutional investors. Top institutional shareholders include EQT Fund Management S.a r.l. (18.76%), Baillie Gifford & Co. (6.80%), Vanguard Group Inc. (6.67%), BlackRock Inc. (3.70%), Riverbridge Partners LLC (2.74%) and Massachusetts Financial Services Co. MA (1.80%). Insiders that own company stock include Avatar Parent LP Eqt, Craig R Rayner, James E Cashman III, Jieun W Choe, Justin Edge, Leif E Pedersen, Mason P Slaine, Matthew M Walsh, Michael Andrew Schemick, Patrick F Smith, Richard M Traynor, Robert Aspbury, Stephen M Mclean and William F Feehery.
View institutional ownership trends
.

How do I buy shares of Certara?

Shares of CERT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Certara's stock price today?

One share of CERT stock can currently be purchased for approximately $15.88.

How much money does Certara make?

Certara (NASDAQ:CERT) has a market capitalization of $2.54 billion and generates $286.10 million in revenue each year. The company earns $-13,270,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis.

How many employees does Certara have?

The company employs 1,114 workers across the globe.

How can I contact Certara?

Certara's mailing address is 100 OVERLOOK CENTER SUITE 101, PRINCETON NJ, 08540. The official website for the company is www.certara.com. The company can be reached via phone at 609-716-7900 or via email at ir@certara.com.

This page (NASDAQ:CERT) was last updated on 11/27/2022 by MarketBeat.com Staff